Pages

▼
Showing posts with label antibodies. Show all posts
Showing posts with label antibodies. Show all posts
Friday, February 21, 2014

Financings of the Fortnight And the Neverending Venture Round

›
Somewhere out there, perhaps, is the end of NovImmune's Series B round. More than a year ago, our friends at START-UP examined the ...
Thursday, September 19, 2013

Financings of the Fortnight Explores the Alternatives

›
With all the noise this year about IPOs in our little corner of the world, it’s been easy to forget that most biotechs out there are scra...
Friday, August 23, 2013

What If Deals Of The Week Had A Party And Nobody Showed Up?

›
What if they had a week and no biopharma deals happened? We’re not quite at that point but it has been slow-going, to put it mildly, on t...
Friday, June 28, 2013

Deals of the Week Gets Better Connected, Dips A Toe In Digital Health

›
Digital health is a bit of a catch-all. It encompasses everything from inexpensive exercise- and diet-recording gadgets to sophisticat...
Friday, May 03, 2013

Financing of the Fortnight Wonders If It's Time To Join The Parade

›
Biotech workers of the world unite, you have nothing to exercise but your stock options. At least a few more do these days. We’re far fro...
Friday, February 22, 2013

Deals Of The Week Wonders What Merck's Latest Biosimilars Move Really Means

›
Ever since Merck jumped into the biosimilar field in 2008 with a ferocious go get ’em attitude more fitting of an NFL tackle than a big ...